SUSMED,Inc. (TYO:4263)
246.00
-4.00 (-1.60%)
Nov 18, 2026, 10:49 AM JST
SUSMED,Inc. Market Cap
SUSMED,Inc. has a market cap or net worth of 4.14 billion as of November 17, 2026. It is the 34,491st most valuable company in the world and the 3,164th biggest in Japan. Its market cap has decreased by 72.97% in one year.
Market Cap
4.14B
Enterprise Value
183.97M
Revenue
679.00M
Global Rank
Country Rank
#3,164 Japan
PE Ratio
n/a
ChartMarket Cap Chart
Since December 24, 2021, SUSMED,Inc.'s market cap has decreased from 28.30B to 4.14B, a decrease of -85.38%. That is a compound annual growth rate of -32.44%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 18, 2026 | 4.14B | -70.85% |
| Dec 30, 2025 | 14.19B | 39.27% |
| Dec 30, 2024 | 10.19B | -54.23% |
| Dec 29, 2023 | 22.26B | 16.38% |
| Dec 30, 2022 | 19.13B | -41.83% |
| Dec 30, 2021 | 32.88B | 16.21% |
| Dec 24, 2021 | 28.30B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BrightPath Biotherapeutics | 5.28B |
| Cyfuse Biomedical K.K. | 5.12B |
| MabGenesis | 4.91B |
| MEDINET | 4.84B |
| Kringle Pharma | 4.67B |
| PRISM BioLab Co.,LTD | 3.96B |
| Noile-Immune Biotech | 3.73B |
| Chordia Therapeutics | 3.56B |